Trials / Completed
CompletedNCT02262520
Phase 1 Drug Interaction Study of the Effect of Apixaban on the PK of Digoxin in Healthy Subjects
Effect of Apixaban on the Pharmacokinetics of Digoxin in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the effects of Apixaban on the Pharmacokinetics (PK) of multiple-dose Digoxin in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Apixaban | |
| DRUG | Digoxin |
Timeline
- Start date
- 2006-01-01
- Primary completion
- 2006-03-01
- Completion
- 2006-03-01
- First posted
- 2014-10-13
- Last updated
- 2015-08-10
Source: ClinicalTrials.gov record NCT02262520. Inclusion in this directory is not an endorsement.